FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Mark Schubert

Research Profile

Disorders

Procedures

Chemicals & Drugs

Living Beings

Co-author Network

Publications

TOP 3
Mark M Schubert; Daniel L Jones
Management of oropharyngeal mucositis pain.
Kim Robien; Mark M Schubert; Yutaka Yasui; Paul Martin; Rainer Storb; John D Potter; Cornelia M Ulrich
Folic acid supplementation during methotrexate immunosuppression is not associated with early toxicity, risk of acute graft-versus-host disease or relapse following hematopoietic transplantation.
Kim Robien; Mark M Schubert; T Chay; Jeannette Bigler; Rainer Storb; Yutaka Yasui; John D Potter; Cornelia M Ulrich
Methylenetetrahydrofolate reductase and thymidylate synthase genotypes modify oral mucositis severity following hematopoietic stem cell transplantation.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Mark Schubert (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Mark M Schubert; Daniel L Jones
Management of oropharyngeal mucositis pain.
Texas dental journal 2010;127(5):463-81.
2006: Kim Robien; Mark M Schubert; Yutaka Yasui; Paul Martin; Rainer Storb; John D Potter; Cornelia M Ulrich
Folic acid supplementation during methotrexate immunosuppression is not associated with early toxicity, risk of acute graft-versus-host disease or relapse following hematopoietic transplantation.
Bone marrow transplantation 2006;37(7):687-92.
2006: Kim Robien; Mark M Schubert; T Chay; Jeannette Bigler; Rainer Storb; Yutaka Yasui; John D Potter; Cornelia M Ulrich
Methylenetetrahydrofolate reductase and thymidylate synthase genotypes modify oral mucositis severity following hematopoietic stem cell transplantation.
Bone marrow transplantation 2006;37(8):799-800.
2005: Richard A Nash; Laura Johnston; Pablo Parker; Jeannine S McCune; Barry Storer; John T Slattery; Terry Furlong; Claudio Anasetti; Frederick R Appelbaum; Michele E Lloid; H Joachim Deeg; Hans-Peter Kiem; Paul J Martin; Mark M Schubert; Robert P Witherspoon; Stephen J Forman; Karl G Blume; Rainer Storb
A phase I/II study of mycophenolate mofetil in combination with cyclosporine for prophylaxis of acute graft-versus-host disease after myeloablative conditioning and allogeneic hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(7):495-505.
2005: David N Fredricks; Mark M Schubert; David Myerson
Molecular identification of an invasive gingival bacterial community.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;41(1):e1-4.
2004: Mark M Schubert; Daniel L Jones
Management of oral mucositis pain.
Texas dental journal 2004;121(6):507-18.
2004: Kim Robien; Mark M Schubert; Barbara Bruemmer; Michele E Lloid; John D Potter; Cornelia M Ulrich
Predictors of oral mucositis in patients receiving hematopoietic cell transplants for chronic myelogenous leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(7):1268-75.
2001: Cornelia M Ulrich; Yutaka Yasui; Rainer Storb; Mark M Schubert; J L Wagner; Jeannette Bigler; K S Ariail; Cassie L Keener; S Li; H Liu; Federico M Farin; John D Potter
Pharmacogenetics of methotrexate: toxicity among marrow transplantation patients varies with the methylenetetrahydrofolate reductase C677T polymorphism.
Blood 2001;98(1):231-4.
2000: Thomas R Chauncey; Theodore A Gooley; Michele E Lloid; Mark M Schubert; Kathy Lilleby; Leona A Holmberg; William I Bensinger
Pilot trial of cytoprotection with amifostine given with high-dose chemotherapy and autologous peripheral blood stem cell transplantation.
American journal of clinical oncology 2000;23(4):406-11.